Cyberonics' NCP
This article was originally published in The Gray Sheet
Executive Summary
Firm plans 30-patient, four-site pilot study of its NeuroCybernetic Prosthesis system for vagus nerve stimulation to treat chronic migraine headaches. Investigational device exemption clearance announced July 19. Device was approved in 1997 for treatment of epilepsy